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ABSTRACT: A suitable and standardized protein purification technique is essential to maintain consistency and to allow data comparison between 
proteomic studies for urine biomarker discovery. Ultimately, efforts should be made to standardize urine preparation protocols. The aim of this study was 
to develop an optimal analytical protocol to achieve maximal protein yield and to ensure that this method was applicable to examine urine protein patterns 
that distinguish disease and disease-free states. In this pilot study, we compared seven different urine sample preparation methods to remove salts, and to 
precipitate and isolate urinary proteins. Sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) profiles showed that the sequential prepa-
ration of urinary proteins by combining acetone and trichloroacetic acid (TCA) alongside high speed centrifugation (HSC) provided the best separation, 
and retained the most urinary proteins. Therefore, this approach is the preferred method for all further urine protein analysis.
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Introduction
The identification of novel biomarkers for the early detection of 
cancer, monitoring cancer progression, and assessing response to 
therapy holds promise for improving clinical outcomes. Currently, 
a major obstacle in the early detection of breast cancer (BC) is the 
development of methods that efficiently and accurately identify 
potential proteomics biomarkers. In BC, most of the urinary 
markers identified to date are metabolomic markers.1,2
Urinary proteome analysis is attractive in clinical pro-
teomics research as urine is relatively simple and easy to collect. 
It is commonly used for the diagnosis and classification of 
diseases.3 As a biological sample, human urine is abundant in 
proteins, which reflects the physiological and the pathological 
state of an individual.4 Because of its complex nature, compounds 
present in urine such as salts,   peptides,   oligosaccharides, and 
glycosaminoglycans (GAG) can interfere with the electropho-
retic migration of other proteins.5 Thus, precipitation and con-
centration steps are essential to purify and isolate the proteins 
of interest. The precipitation of proteins occurs in solutions of 
extreme ionic strength, high concentrations of organic sol-
vents, and low pH. Most proteomic researchers use different 
protocols, devised to suit the biological specimen or analytes 
of interest. These protocols include ultrafiltration,6 ethanol 
precipitation,7 various concentrations of acetone,8 acetone and 
trichloroacetic acid (TCA) combination,9,10 ultrafiltration, and 
combination of TCA and ultracentrifugation.11,12
Although there are numerous published urine prepara-
tion protocols, when applied to the metastatic BC specimens Beretov et al
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in our laboratory, these existing techniques could not effi-
ciently desalt and concentrate the urine samples.
No group of investigators to date have published stan-
dardized technical information on the preparation of urine 
to achieve maximal protein yield for BC protein biomark-
ers. The validity of the BC biomarker discovery greatly relies 
on the handling of urine samples in a uniform manner, thus 
highlighting the importance of a standardized protocol. Here, 
we demonstrate an efficient and reliable technical method 
including the sequential preparation of urinary proteins by 
acetone, and TCA in combination with high speed centrifu-
gation (HSC) for urine sample preparation. We found that 
this approach can maintain consistency and reproducibility to 
allow urinary data comparison.
Materials and Methods
Urine collection protocol. In this pilot study, urine sam-
ples were collected from female patients (ranging 35–60 years) 
with metastatic BC (n = 15) and age-matched healthy disease-
free control group (n = 18). Prior ethical approval for this study 
was obtained from the Human Research Ethics Committee of 
South Eastern Area Health Service Ethics Committee (SEA 
HRCE #07/71Li). The study was conducted in accordance 
with the Declaration of Helsinki. All subjects provided their 
written, informed consent to participate. All urine samples 
were collected as a midstream, clean catch specimen into a 
sterile urine container and immediately transported on ice to 
prevent microbe contamination and proteolysis. The samples 
were then clarified and insoluble materials were removed by 
centrifugation at 2,000 × g (4,000 rpm) at 4°C for 10 min-
utes,5 within 30 minutes (min) of collection, to prevent protein 
release from these artifacts. The supernatants were carefully 
removed and frozen at -20°C in 2 mL aliquots to prevent 
freezing-and-thawing cycles (transferred to -80°C for long-
term storage). The biological characteristics of urine samples 
were examined for color (pale yellow, no blood), turbidity 
(clear not cloudy), and pH (4.5–8.0) to ensure that there were 
no notable discrepancies. To prevent technical and analytical 
variation caused by handling, all samples were collected, pro-
cessed, and stored following the same procedural conditions, 
and by the same laboratory personnel until a final protocol was 
established. Protease inhibitors were not used in this study.
Protein extraction and precipitation techniques. To 
achieve a representative urinary proteome that portrays the 
group pattern sample variability,13 the frozen aliquots were 
completely thawed, mixed well, and then equal volumes of each 
donor supernatant were pooled into the BC or control group.
The pooled urine supernatants were subjected to seven 
different urine protein extraction–precipitation methods, along 
with various combinations of these techniques (summarized 
in Table 1). The main precipitation techniques (methods 1–4) 
included acetone, TCA, ultrafiltration (UF), and acetone plus 
TCA combined. All precipitation procedures were performed 
at 4°C, and in methods 1–4, the samples were initially 
centrifuged at a low speed centrifugation (LSC), then repeated 
at HSC to attempt to further desalt and remove non-soluble 
materials. All supernatant washes for each technique were kept 
and analyzed for protein loss. The details of all the urine pro-
tein precipitation methods applied are as follows:
(1) Acetone method: Eight parts of ice-cold acetone were 
combined with one part of urine sample (1:8 urine sample-
to-solvent ratio), and the mixture was stored at -20°C for 
1 hour. The pellets were air-dried to remove residual acetone; 
(2) TCA method: One part of fresh TCA solution (10 g TCA 
in 10 mL Milli-Q H2O) was added to four parts of urine 
(4:1 urine sample-to-solvent ratio), and the mixture was vor-
texed and then incubated for 1 hour at 4°C; (3) Ultrafiltration 
method: This approach was carried out according to the pro-
cedure provided with the device (Amicon® Ultra-15 Centrifu-
gal Filter Units, Millipore, Darmstadt, Germany) in order to 
reduce the initial volume of urine to 500 µL; (4) Combined 
acetone/TCA method: Acetone precipitation was performed 
for 1 hour at -20°C (as per method 1), dried-off for 5 minutes 
at room temperature, followed by TCA precipitation (as per 
method 2), vortexing, and then incubation for 1 hour at 4°C. 
All protein pellets were initially collected at LSC (Optima LE-
80K; Beckman Coulter, Inc., Fullerton, CA, USA) at 4,000 × g 
for 30   minutes; (5) HSC method: This approach includes the 
application of HSC, centrifugation at 11,000 × g for 30 minutes 
after each precipitation method 1–4 (see Table 1: method 5) to 
concentrate the protein samples.
Additional purification steps that included either GAG 
precipitation5,14 or sonication-“cell shearing” were exam-
ined separately with each single precipitation method (1–4); 
the combined techniques applied are listed in Table 1. The 
details of the double precipitation methods include (6); GAG 
precipitation method: Following precipitation with the single 
methods (1–4) at HSC (method 5), each protein pellet was 
incubated at 26°C for 30 minutes in a 5% cetyl pyridinium 
chloride (CPC) solution (CPC solution-to-protein pellet ratio 
3:1), and then washed twice with 1 M NaCl (sodium chloride) 
solution to disrupt the CPC–GAG complex; and (7) sonica-
tion-“cell shearing” method. Following each of the methods 
(1–4) at HSC (method 5), the urine protein pellets were 
resuspended in 100 µL lysis buffer (7 M urea, 0.1 M CHAPS 
(3-[(3 cholamidopropyl)dimethylammonio]-1-propanesulfo-
nate), 0.1 M dithioerythritol [DTT], and 35 mM Tris-base) 
and 0.1 g of zirconium beads (0.1 mm diameter). Samples were 
sheared at 5,000 rpm in a mini-bead beater (Biospec Prod-
uct, Oklahoma, USA) for 90 seconds and then kept on ice for 
5 minutes to limit heating. This procedure was repeated three 
times. After briefly centrifuging on a mini spin bench top, the 
samples were centrifuged at 10,000 × g for 10 minutes, and the 
supernatants were carefully collected for HSC for 45 minutes.
The precipitated protein pellets from all methods were 
resuspended and solubilized in 100 µL of rehydration buffer 
(RB), 7 M urea, 2 M thiourea, 1% CHAPS, 50 mM DTT, for 
protein assay analysis and sodium dodecyl sulfate-polyacrylamide A standardized and reproducible urine preparation protocol for cancer 
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Table 1. summary of all the urine precipitation techniques applied.
METHOD 
APPLIED
PRECIPITATION  
TECHNIQUE
SAMPLE VOLUME PRECIPITATION TIME/ 
TEMPERATURE
CENTRIFUGATION  
SPEED × (g) AT 4°C
TIME PROTEIN 
PELLET 
EXTRACTED 
1 acetone sample: acetone
1:8
1 hour at -20°C Low speed 
centrifugation
(LsC) 
30 min Y
2 Trichloroacetic-acid (TCa)  sample: TCa
 4:1 
1 hour at 4°C LsC 30 Y
3 Ultra-filtration (UF) 15 mL LsC 30 Y
4 acetone/TCa sample: acetone (1:8)
sample: TCa (4:1) 
1 hour at -20°C
1 hour at 4°C
LsC
LsC
30
30
Y
5 High speed centrifugation  
(HsC)
11,000 30
1, 5 acetone-HsC HsC 30 Y
2, 5 TCa-HsC HsC  30 Y
3, 5 UF-HsC HsC 30 Y
4, 5  acetone/TCa-HsC HsC 30 Y
6 Glyco-ammino glycan  
removal (GaG)
CPC: pellet (3:1) 30 min at 26°C 11,000 30
1, 5, 6 acetone-HsC-GaG HsC 30 n
2, 5, 6 TCa-HsC-GaG HsC 30 n
3, 5, 6 UF-HsC-GaG HsC 30 n
4, 5, 6 acetone/TCa-HsC-GaG HsC 30 Y
7 Cell shearing (Cs) 100 µL lysis
buffer
Bench top
11,000
10
45
1, 5, 7 acetone-HsC-Cs Y
2, 5, 7 TCa-HsC-Cs n
3, 5, 7 UF-HsC-Cs n
4, 5, 7 acetone/TCa-Cs Y
Notes: The seven urine preparation methods (1–7) including 16 individual approaches are shown. The main precipitation techniques are methods 1–4; HsC (5) 
has four combination approaches with methods 1–4; GaG (6) has four combination approaches with methods 1–4; cell shearing (7) also has four combination 
approaches with methods 1–4. at the end of each extraction method, the ability to achieve a protein pellet was shown.
Abbreviations: CPC, cetyl pyridinium chloride solution; Y, protein pellet was extracted; n, no protein pellet was extracted.
gel electrophoresis (SDS-PAGE). The samples were subjected 
to protein quantitation using the 2-D Quant kit (GE Health-
care, USA), with bovine serum albumin (BSA) as a reference 
standard. Numerous protein assays were conducted and a stan-
dard curve was established for each assay. All samples were run 
in triplicate. The standard curve was used to create a trend line 
and a linear equation established was used to calculate the pro-
tein values with R2  0.99.
Protein separation and examination. SDS-PAGE was 
used to determine the best method for the extraction and pre-
cipitation for liquid-chromatography/tandem-mass spectrom-
etry (LC-MS/MS). A volume of protein solution was taken to 
load 30 µg of protein, which was mixed with an equal volume 
of TruSep SDS sample buffer (NuSep, Homebush, NSW, 
Australia) and boiled for 5 minutes. The whole sample was 
run on 12%T-Tris/glycine precast mini gels at 180 V, 50 mA/
gel for 1 hour with Tris-glycine running buffer (25 mM Tris, 
192 mM glycine, and 0.1% SDS in Milli-Q H2O pH 8). Gels 
were stained using a solution of Coomassie Blue R-250, 0.1% 
w/v in 10% methanol (CB R-250).
Protein desalting was done with C18 Stage Tips (Ther-
moScientific, Waltham, MA, USA.) as recommended by the 
manufacturer. Peptide fractions were digested with trypsin 
(12.5 ng/µL trypsin proteomic grade, Sigma-Aldrich, St. Louis, 
MO, USA) to a final enzyme:protein ratio of 1:100 (w/w). All 
the samples were digested and prepared for LC-MS/MS anal-
ysis using equivalent fixed amounts of protein starting mate-
rial of 10 µg. Analysis was conducted on the protein digests 
by LC-MS/MS using a LTQ-Velos Orbitrap ETD (Thermo 
Electron, Bremen, Germany) as described previously.15 Briefly, 
C18-LC elution was conducted over 60-minute linear gradi-
ents. The false discovery rate (FDR) was less than 2% at 95% 
confidence for peptides. Protein datasets (Peak lists) were 
generated using Mascot Daemon software (Matrix Science, 
London, England), and analyzed using Peak Integration with 
Progenesis LC-MS (Non-Linear Dynamics, UK).Beretov et al
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Results
Urinary proteins examined on SDS-PAGE and 
identified with LC-MS/MS. Our results clearly indicate that 
the quality and the variability of the urinary protein recov-
ery were greatly affected by the preparation protocols used. 
Initially, precipitation methods 1–4 were performed at LSC, 
and no MS data was detected in these protein sample extracts 
(Table 2: A1–2, C1–3). Additionally, the excessive drag in the 
gel results from the metastatic BC urine samples (Fig. 1: C1–3) 
demonstrated a difference between the metastatic BC and the 
control samples (Fig. 1: A2). Therefore, additional desalting 
steps to clarify the sample further were required. To observe 
the optimal method for urine sample preparation for meta-
static BC and healthy control urine samples, seven different 
urine precipitation techniques were compared. This informa-
tion was used to determine the method that could provide the 
highest resolution on SDS-PAGE and the greatest number of 
urinary proteins detected with LC-MS/MS.
A total of 20 gels were examined, which included each 
protein extraction method, where a pellet was extracted 
(see Table 1), being run at least five times across several dif-
ferent gels. The four representative gels demonstrate the pro-
tein extracts achieved following the application of the seven 
different precipitation techniques in various combinations 
Table 2. Summary of the number of proteins identified with LC-MS/MS and total protein extracted with the different urine protein precipitation 
methods.
SDS-PAGE ID PROTEIN PRECIPITATION  
TECHNIQUE
METHOD N0 TOTAL PROTEIN 
EXTRACTED (mG)
N0 OF PROTEINS 
ID WITH LC-MS/MS
Normal control urine samples—LSC and HSC 
m Mass Marker
a1 TCa LsC  2  215 nD
a2 acetone LsC  1 576 nD
a3 TCa at HsC 2, 5 345 73
a4 acetone at HsC 1, 5 905 113
a5 Ultra filtration  3 187 47
a6 acetone/TCa* at HsC 4, 5 987  149*
Normal control urine samples, HSC 
B1 acetone  1, 5 834 115 
B2 acetone and Cell shearing 1, 5, 7 676 70
B3 TCa  2, 5 476 79
B4 acetone/TCa* 4, 5 1184  154*
B5 acetone/TCa - CPC  4, 5, 6 93, 55 nD
B6 acetone/TCa and Cell shearing  4, 5, 7 313 55
Metastatic BC urine samples—LSC 
C1 acetone 1 155 nD
C2 TCa 2 146 nD
C3 acetone/TCa  4 202 nD
C4 Ultra filtration at HSC 3, 5 108  nD
C5 all CPC washes 30#
C6 all acetone washes 30#
Metastatic BC urine samples—all HSC 
D1 acetone 1, 5 865 117
D2 TCa 2, 5 589 nD
D3 acetone/TCa* 4, 5 1023 165, 167*
D4 all TCa washes 20#
D5 all acetone/TCa washes  20#
Notes: all urine precipitation methods are tabulated against the protein concentration, in both disease-free control (shown in a–B) and BC specimens (C–D). 
Corresponding gel images are shown in Figure 1. The majority of the techniques employed HsC centrifugation (11,000 × g) at 4°C for 30 minutes (except a1–2, 
a5, and C1–3 where LsC was applied). *Highlights the precipitation technique (acetone/TCa at HsC) with the highest total protein extract and number of proteins. 
#indicates there was minimal loss of protein found in the washes.
Abbreviations: CPC, cetyl pyridinium chloride; HSC, high speed centrifugation; ID, identified; LSC, low speed centrifugation (4,000 × g); n0, number; nD, not 
detected; TCa, trichloroacetic acid.A standardized and reproducible urine preparation protocol for cancer 
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(Fig. 1). The total protein extracted and LC-MS/MS data, 
which correspond to the SDS-PAGE results (Fig. 1), are sum-
marized in Table 2.
Combination approach with acetone, then TCA at 
HSC. Overall, the greatest number of urinary proteins and 
total protein yield, representing both the high and low molec-
ular weight (MW) proteins, as well as best gel resolution, 
were observed by combining three precipitation techniques 
(ie acetone, then TCA all using HSC, see methods 4 and 5) in 
both the control and BC samples (Fig. 1 and Table 2 in *A6, 
B4, and D3). The number of MS/MS spectra obtained from 
the peptide and protein identified (using Mudpit approach 
with SCX and C18 separation prior to MS, ~13-hour run) 
for both labeled and unlabeled analysis (Table 2) showed 
the increased number of proteins identified in both the BC 
(159, 167) and control samples (149, 154), compared to ace-
tone alone (methods 1 and 5) with only 117 and 115 proteins 
identified in the same samples. The efficiency of the acetone/
TCA at HSC technique (methods 4 and 5) was supported by 
the increase in the concentration of the total protein extracted 
for each sample (around 1,000 µg) and was also confirmed 
by minimal protein loss demonstrated in the washes (Fig. 1 
and Table 1: D5). A Venn diagram was used to demonstrate 
that an increased number of proteins were identified by 
LC-MS/MS using the acetone/TCA protein precipitation 
at HSC technique in both the control (Fig. 2A) and meta-
static BC (Fig. 2B) urine samples. Unfortunately, the appli-
cation of double precipitation with cell shearing showed no 
Figure 1. The comparison of urinary protein precipitation methods on SDS-PAGE. The effects of precipitation techniques and centrifugation on 
urinary proteins were examined on healthy control (A–B, n = 18) and metastatic BC samples (C–D, n = 15). The details of the technique employed, total 
protein concentrations, and number of proteins identified by LC-MS/MS are summarized in Table 2.
Figure 2. Venn diagram comparison of proteins identified by LC-MS/MS in the control and metastatic BC samples following acetone and 
acetone/TCA precipitation. The two major precipitation techniques, acetone and acetone/TCa, were compared for the urine samples from healthy 
controls (A) and metastatic BC patients (B). The MS data (Table 2) for the protein extracts indicated that an increased number of proteins were identified 
in the acetone/TCa protein precipitates in both the controls (154) and BC samples (167), compared to 115 and 117, respectively. The overlap represents 
the proteins in common.Beretov et al
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additional benefit and instead led to the loss of proteins with 
each sequential extraction (Fig. 1: B2, B6).
Urinary proteins in BC and control samples at HSC. 
Comparing all the precipitation techniques (methods 1–4), 
our gel results clearly demonstrated that the HSC was essen-
tial to desalt and remove non-soluble materials, and isolate 
urinary proteins in the BC samples (Fig. 1: C1–3 LSC against 
D1–3 HSC). As mentioned above, the LC-MS/MS data 
confirmed that urine proteins extracted using methods 1–4 
with LSC were either not detectable or low (Table 2: controls 
A1–2 and BC samples C1–4). However, the same methods 
with HSC could achieve a far superior extraction for both the 
control (Fig. 1: A3–4, B1–4) and BC samples (Fig. 1: D1–3).
Precipitation with organic solvent and acid alone. 
Although the application of HSC (method 5) has been shown 
to be more effective in desalting and concentrating the urine 
samples, acetone (method 1, see Fig. 1: A4, B1, and D1) was 
more successful than TCA (method 2) as shown on SDS-
PAGE (Fig. 1: A3, B3, and D2). This finding was further con-
firmed with the LC-MS/MS data from acetone (Table 2: A4, 
B1, and D1) and TCA (Table 2: A3, B3, and D2). Our results 
also demonstrated that the combination of organic solvent and 
acid with HSC (method 4 and 5) provided a superior extract 
(Fig. 1 and Table 2: A6, B4, and D3).
Other precipitation methods. In addition to the above-
mentioned methods, we also found that ultrafiltration of urine 
was not an effective protein precipitation technique (Fig. 1: 
A5 and C4), the protein extracts from this method had a low 
protein yield and were difficult to detect with MS (Table 2: 
A5 and C4).
To achieve an increased protein yield, a double precipita-
tion method was applied, in which urinary proteins were first 
precipitated by one of the methods 1–4 at HSC (5), and then 
the pellet was re-precipitated with the CPC method to remove 
the GAG. Although this technique was attempted numer-
ous times, it was ineffective in further purifying the samples. 
Instead, there was aggregation and high salt contamination 
on the gels (Fig. 1: B5). Despite clean-up attempts using SCX 
and C18 stage tips, this method showed the least total protein 
extract, and proteins were not detectable using MS (Table 2: B5),  
even though the washes indicated no protein loss (Fig. 1: C5).   
This technique was very laborious with excessive sample 
handling and is not recommended.
Our results indicate that the approach of acetone/TCA at 
HSC is an optimal method for increased protein yield, num-
ber of protein detected with LC-MS/MS, ease of handling, 
and reproducibility compared to other approaches.
Discussion
In the current study, our objective was to determine the best 
method to achieve the highest yield from urine samples for 
future biomarker discovery of BC patients. To achieve a com-
prehensive comparison for the preparation of urinary proteins, 
seven different techniques were systematically investigated, 
which included 16 individual precipitation approaches. To 
optimize the removal of proteins, the techniques applied 
examined the effect of organic solvent, acid, and ultrafiltra-
tion. We found that a combination of organic solvent and acid 
all at LSC and then HSC along with two additional purifica-
tion steps included eight combination approaches (Table 1). 
Although 16 approaches (single methods: 1–4; combination 
methods: 5–7) were investigated, only 11 of the techniques 
successfully achieved a protein pellet. The effectiveness of 
these different techniques was different as shown on SDS-
PAGE and LC-MS/MS (Table 2). SDS-PAGE technique 
allowed for the identification of abundant proteins. The clar-
ity, drag, aggregation, and number of distinct bands are good 
indicators of the downstream success in the identification of 
proteins related to the contaminants, salts, chemical degrada-
tion, and sampling degradation content within the samples.
LC-MS/MS is one of the most popular proteomic tech-
niques and requires a very small volume of protein sample for 
analysis. Because of the low concentration of urinary proteins 
and high concentration of salt and metabolites, the purity 
of the urine protein pellet for proteomic analysis is critical. 
Therefore, the aim is to consistently achieve a high quality 
recovery, urinary proteins extract for downstream analysis. The 
data presented here clearly demonstrate the importance of 
the precipitation and concentration method applied to urine 
samples. Although other literature show a common theme for 
urine collection, processing, and downstream analysis,16 our 
current study is only a guide to the development of a standard 
method. The precipitation of urine proteins occurs in solu-
tions of extreme ionic strength, high concentrations of organic 
solvents, and low pH. Our findings indicate that the tech-
niques applied to urine preparation described in the literature 
were unsuccessful when applied to our metastatic BC urine 
samples. We found that aggregation and high salt concentra-
tion in most of the protein extracts from BC urine samples 
made it difficult to obtain sufficient MS spectra. Following 
a detailed review of urine sample preparation, using differ-
ent techniques for proteomic biomarker studies in BC,17 we 
modified the urine preparation techniques to improve protein 
yield for MS analysis.
In this study, the most robust and reproducible techniques 
were acetone at HSC (methods 1 and 5) and acetone/TCA at 
HSC (methods 4 and 5). Overall, the best resolution on the 
gels and the highest number of proteins were achieved using 
the precipitation with acetone/TCA at HSC in both the meta-
static BC and control urine samples. Our results demonstrate 
an optimized urine sample preparation method, which allows 
us to obtain the best urinary protein MS data. This recom-
mended method can produce a protein-rich fraction and limit 
protein loss. In addition, we also found that this approach is a 
robust and reproducible analytical protocol that can separate 
the proteins from interfering compounds and achieve the max-
imum yield of protein precipitate with minimal sample han-
dling. Furthermore, the protein fraction from this method can A standardized and reproducible urine preparation protocol for cancer 
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produce the highest resolution on SDS-PAGE and the great-
est number of proteins by LC-MS/MS.
Urine sample preparation is a complicated process. There 
is no standardized urine sample preparation method currently 
available. The experimental design for urine sample prepa-
ration should also include sample collection and storage as 
sample collection and storage are crucial to the final protein 
analysis. The pooled urine specimens, within disease and non-
disease states, can enhance the population proteins to estimate 
the prevalence of disease in the population and dilute the nat-
ural biological variance for proteomic studies.
In summary, although some progress has been made, 
challenges still remain in the development of an optimal 
sample preparation method for proteomic analysis of urine for 
gel-based electrophoresis and label-free LC-MS/MS analy-
sis. This study provides optimal conditions for urinary protein 
precipitation for our metastatic BC samples. We demonstrate 
that the acetone/TCA at HSC is the most promising approach 
for urine preparation. Our current recommended urine prepa-
ration approach also includes the assessment of biological 
characteristics to ensure that there are no major underlying 
conditions that could affect urine stability and its analysis. 
The discovery of novel proteins and the validity of biomarker 
discovery greatly rely on the handling of urine samples in a 
uniform manner and thus highlight the need for a reproduc-
ible standardized protocol.
Abbreviations
BC, breast cancer; BSA, bovine serum albumin; CPC, cetyl 
pyridium chloride; FDR, false discovery rate; GAG, glyco 
amino glycan; HSC, high speed centrifugation; LC-MS/
MS, liquid-chromatography/tandem-mass spectrometry; MS, 
mass spectrometry; RB, rehydration buffer; SDS-PAGE, 
sodium dodecyl sulphate-polyacrylamide gel electrophoresis; 
TCA, trichloracetic acid; UF, ultrafiltration.
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